Europe Medical Second Opinion Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis.

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Report Coverage:
  • Condition (Cancer, Orthopedic Disorders, Cardiac Disorders, Neurological Disorders, Nephrological Disorders, Hematological Blood Disorders, COPD, Organ Transplant, Others)
  • Service Provider (Hospitals, Health Insurance Companies, Online Services)

No. of Pages: 116
Report Code: TIPRE00025236
Category: Life Sciences
Europe Medical Second Opinion Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Medical Second Opinion Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Medical Second Opinion Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Medical Second Opinion Market Regional Analysis

6.2 Europe Medical Second Opinion Market Revenue 2021-2031 (US$ Million)
6.3 Europe Medical Second Opinion Market Forecast Analysis

7. Europe Medical Second Opinion Market Analysis – by Condition

7.1 Cancer
  • 7.1.1 Overview
  • 7.1.2 Cancer: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Orthopedic Disorders
  • 7.2.1 Overview
  • 7.2.2 Orthopedic Disorders: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Cardiac Disorders
  • 7.3.1 Overview
  • 7.3.2 Cardiac Disorders: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Neurological Disorders
  • 7.4.1 Overview
  • 7.4.2 Neurological Disorders: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Nephrological Disorders
  • 7.5.1 Overview
  • 7.5.2 Nephrological Disorders: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Hematological Blood Disorders
  • 7.6.1 Overview
  • 7.6.2 Hematological Blood Disorders: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.7 COPD
  • 7.7.1 Overview
  • 7.7.2 COPD: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.8 Organ Transplant
  • 7.8.1 Overview
  • 7.8.2 Organ Transplant: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.9 Others
  • 7.9.1 Overview
  • 7.9.2 Others: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Medical Second Opinion Market Analysis – by Service Provider

8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Hospitals: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Health Insurance Companies
  • 8.2.1 Overview
  • 8.2.2 Health Insurance Companies: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Online Services
  • 8.3.1 Overview
  • 8.3.2 Online Services: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Medical Second Opinion Market – Europe Analysis

9.1 Overview

9.2 Europe
  • 9.2.1 Europe Medical Second Opinion Market Breakdown, by Key Country, 2024 and 2031 (%)
  • 9.2.1.1 Europe Medical Second Opinion Market – Revenue and Forecast Analysis – by Country
  • 9.2.1.1 Germany: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
    • 9.2.1.1.1 Germany: Europe Medical Second Opinion Market Breakdown, by Condition
    • 9.2.1.1.2 Germany: Europe Medical Second Opinion Market Breakdown, by Service Provider
  • 9.2.1.2 France: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
    • 9.2.1.2.1 France: Europe Medical Second Opinion Market Breakdown, by Condition
    • 9.2.1.2.2 France: Europe Medical Second Opinion Market Breakdown, by Service Provider
  • 9.2.1.3 Italy: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
    • 9.2.1.3.1 Italy: Europe Medical Second Opinion Market Breakdown, by Condition
    • 9.2.1.3.2 Italy: Europe Medical Second Opinion Market Breakdown, by Service Provider
  • 9.2.1.4 UK: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
    • 9.2.1.4.1 UK: Europe Medical Second Opinion Market Breakdown, by Condition
    • 9.2.1.4.2 UK: Europe Medical Second Opinion Market Breakdown, by Service Provider
  • 9.2.1.5 Spain: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
    • 9.2.1.5.1 Spain: Europe Medical Second Opinion Market Breakdown, by Condition
    • 9.2.1.5.2 Spain: Europe Medical Second Opinion Market Breakdown, by Service Provider
  • 9.2.1.6 Rest of Europe: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
    • 9.2.1.6.1 Rest of Europe: Europe Medical Second Opinion Market Breakdown, by Condition
    • 9.2.1.6.2 Rest of Europe: Europe Medical Second Opinion Market Breakdown, by Service Provider

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments

12. Company Profiles

12.1 Second Opinion International
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Elite Medical Services
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 The Cigna Group
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Helsana
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 WorldCare
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Vidal Health Insurance TPA Pvt Ltd
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 2nd.MD
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Axa SA
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 Teladoc Health Inc
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
12.10 Included Health, Inc.
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments
12.11 Royal Doctors
  • 12.11.1 Key Facts
  • 12.11.2 Business Description
  • 12.11.3 Products and Services
  • 12.11.4 Financial Overview
  • 12.11.5 SWOT Analysis
  • 12.11.6 Key Developments

13. Appendix

13.1 About Business Market Insights
13.2 List of Abbreviations

The List of Companies - Europe Medical Second Opinion Market

  • Second Opinion International
  • Elite Medical Services
  • The Cigna Group
  • Helsana
  • WorldCare
  • Vidal Health Insurance TPA Pvt Ltd
  • 2nd.MD
  • Axa SA
  • Teladoc Health Inc
  • Included Health, Inc.
  • Royal Doctors
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)